Skip to main navigation Skip to search Skip to main content

Researchers from Mitoimmune Therapeutics Inc. Describe Findings in Inflammatory Bowel Disease (MIT-001, a Mitochondria-Targeted ROS Scavenger, Ameliorates DSS-Induced Colitis and Is Associated with Reduced HMGB1 and IL-1b Expression)

Press/Media: Press / Media

Period2026 Jul 27

Media coverage

1

Media coverage